drugset / Trial / NCT01916187
Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the best dose of imetelstat when given alone for patients with neuroblastoma and also when given in combination with 13-cis-retinoic acid.
Timeline
- Start
- 2013-07-30
- Primary completion
- 2013-11-22
- Completion
- 2014-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imetelstat | Oligonucleotide (other) | 285 mg/m2 | Intravenous |